PepsiCo, Cloudflare, Pinterest, Expedia and more
Check out the companies making headlines before the bell: PepsiCo — Shares slipped 1.4% after the beverage and snacks giant reported mixed fourth-quarter results. Revenue came in at $27.85 billion,…
2024-03-29 09:14:40
Check out the companies making headlines before the bell: PepsiCo — Shares slipped 1.4% after the beverage and snacks giant reported mixed fourth-quarter results. Revenue came in at $27.85 billion,…
Check out the companies making headlines in midday trading. Unity Software — The gaming technology stock dropped 8% after announcing Monday it’s cutting 1,800 positions , or about 25% of…
Rafael Henrique | Lightrocket | Getty Images Gene sequencing company Illumina said on Sunday it will divest cancer diagnostic test maker Grail after the companies battled both U.S. and European…
Check out the companies making headlines in midday trading. Groupon — Shares plunged 34.8%, a day after the online marketplace company posted third-quarter revenue and global gross billings that fell…
Carl Icahn speaking at Delivering Alpha in New York on Sept. 13, 2016. David A. Grogan | CNBC Carl Icahn on Thursday expressed his support for Illumina’s new CEO Jacob…
A building on the campus at the world headquarters of Illumina is shown in San Diego, California, Sept. 1, 2021. Mike Blake | Reuters Illumina’s board on Tuesday named Jacob…
A building on the campus at the world headquarters of Illumina is shown in San Diego, California, September 1, 2021. Mike Blake | Reuters The Securities and Exchange Commission is…
Rafael Henrique | Lightrocket | Getty Images Republican lawmakers, state attorneys general and several advocacy groups have voiced their support for Illumina’s acquisition of cancer-test developer Grail while the Federal…
Francis deSouza, chief executive officer of Illumina Inc., during a panel session on day three of the World Economic Forum (WEF) in Davos, Switzerland, on Thursday, Jan. 19, 2023. Stefan…
Rafael Henrique | Lightrocket | Getty Images Activist investor Carl Icahn on Thursday won enough support from Illumina shareholders to install one of his three nominees to the biotech company’s…